HOME >> MEDICINE >> NEWS
Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies

While the raccoon that raids your trash at night may look cute and mischievous, think again. Its claws can be nasty. Even worse, it might carry rabies.

Now, scientists at Jefferson Medical College in Philadelphia and at Molecular Targeting Technologies, Inc. (MTTI) in West Chester, Pa., are taking steps to prevent the disease. They have created a more powerful, safer vaccine than currently is available to combat rabies in wildlife.

Wildlife rabies is no small matter in this country. It's particularly prevalent along the East Coast, and more than 90 percent of reported cases of rabies in all are in wildlife. Raccoons are the most affected, with skunk a close second. Worldwide, and especially in underdeveloped nations, rabies takes a large human toll: More than 60,000 human deaths a year.

In work published December 9 in the journal Vaccine, researchers led by Bernhard Dietzschold, DVM, professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University, created a new live rabies vaccine by manipulating the virus itself, making it much weaker than before. The scientists also made the vaccine much more immunogenic, meaning it aroused a much more robust response from the immune system.

"The advantages of our vaccine are its lack of pathogenicity and the fact that it's much more immunogenic," he says. Live virus vaccines always carry the potential to actually cause the disease they are designed to prevent.

"We have developed a very specific rabies vaccine which displays high titers and the lack of pathogenicity for immunocompetent mice even after many passages," says Dr. Dietzschold, meaning that the vaccine retained its potency over time. "This novel rabies vaccine will be an excellent candidate for immunization of stray dogs and wildlife."

"We have found a master key to turn on and off the pathogenicity of the virus," says Chris Pak, Ph.D., MTTI president and CEO. "We are extremely pleased with these p
'"/>


8-Dec-2004


Page: 1 2

Related medicine news :

1. Jefferson Lab medical imager spots breast cancer
2. Jefferson scientists uncover potential trigger of diabetic kidney disease
3. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
4. Jefferson scientists help explain statins effects in Alzheimers disease
5. Jefferson scientists find zinc may help prevent esophageal, oral cancers
6. Jefferson virologists coax HIV out of hiding
7. Jefferson scientists find way to see breast cancer activity from outside the body
8. Jefferson scientists use gene therapy to rescue failing hearts in animals
9. Jefferson scientists reveal how some types of rabies invade the brain
10. Jefferson neuroscientists studying new type of Alzheimers drug to halt disease progression
11. Jefferson scientists uncover new evidence to help explain statins effects in Alzheimers disease

Post Your Comments:
(Date:11/21/2014)... First Choice Emergency Room ... new facility is located at 225 E. Parkwood Drive, ... are pleased to join the Friendswood community and look ... here,” said Dr. Siddiqi, Facility Medical Director of First ... the opening, First Choice Emergency Room made a donation ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 M3 Global ... verified healthcare professional panel, today announced two important leadership changes ... Roni DasGupta as President of Market Research, Americas and the ... Europe. , Ms. DasGupta joined M3 in 2011 ... most recently Head of Sales. Roni has over 17 ...
(Date:11/21/2014)... By Dennis Thompson ... -- Overweight or obese women who get pregnant are much ... disease as an adult, new research suggests. But it ... in that trend, the researchers added. "Mothers who are ... study author Dr. Michael Mendelson. He is a research fellow ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Some people with cochlear ... internal magnet when they undergo an MRI scan, a ... by the researchers, about 300,000 people worldwide have cochlear ... people who are deaf or have severe hearing loss. ... with cochlear implants when undergoing MRI. One expert ...
(Date:11/21/2014)... By Serena Gordon ... -- Two U.S. government agencies have proposed new rules ... a clinical trial was successful or not. The ... required to publish summaries of their results to ClinicalTrials.gov -- ... of Health (NIH) and the U.S. Department of Health and ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2Health News:Kids Born to Overweight Moms May Face Higher Heart Risks as Adults 2Health News:MRI Can Be Painful, Disruptive for People With Cochlear Implants 2Health News:U.S. Proposes Greater Public Access to Data From Clinical Trials 2
(Date:11/18/2014)... , Nov. 18, 2014  NxStage ® ... leading manufacturer of innovative dialysis products , ... Express dialyzer for the in-center, hemodialysis market. ... which is designed to reduce the amount of ... the number of touch point contamination sites.  The ...
(Date:11/18/2014)... N.J. , Nov. 18, 2014 ... 230,000 American women this year who get a ... today announced new resources for case managers to ... and 5—to navigate the myriad physical, emotional and ... resources are available at no cost via the ...
(Date:11/18/2014)... , Nov. 18, 2014  TransCelerate BioPharma ... most recent manuscript on Risk-Based Monitoring (RBM), ... Quality Control Measure in Clinical Trials ," ... Innovation & Regulatory Science  (TIRS) journal. Developed ... with Medidata, the manuscript examines the value ...
Breaking Medicine Technology:NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3
Cached News: